icon fsr

文献詳細

雑誌文献

臨床検査61巻7号

2017年07月発行

文献概要

今月の特集 造血器・リンパ系腫瘍のWHO分類 2016 version リンパ系腫瘍

—成熟B細胞腫瘍—びまん性大細胞型Bリンパ腫,EBウイルス陽性大細胞型Bリンパ腫,Burkittリンパ腫,高悪性度リンパ腫

著者: 山崎悦子1

所属機関: 1横浜市立大学附属病院臨床検査部

ページ範囲:P.847 - P.853

文献購入ページに移動
Point

●DLBCL, NOSは免疫染色アルゴリズムを用いて,胚中心B細胞型(GCB)型とnon-GCB型に分類する.

●2008年版の“EBV-positive DLBCL of the elderly”は,2016年版でEBV large B-cell lymphomas(EBウイルス陽性大細胞型Bリンパ腫)と改名され,EBV mucocutaneous ulcerは独立した疾患カテゴリーとなった.

●2008年版の“B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and BL”は,2016年版ではMYCとBCL2 and/or BCL6の遺伝子再構成をもつ“high-grade B-cell lymphoma (HGBL), with MYC and BCL2 and/or BCL6 rearrangements”と,再構成をもたない“HGBL, NOS”に分かれた

参考文献

1)Young RM, Shaffer AL 3rd, Phelan JD, et al:B-cell receptor signaling in diffuse large B-cell lymphoma. Semin Hematol 52:77-85,2015
2)Roschewski M, Staudt LM, Wilson WH:Diffuse large B-cell lymphoma-treatment approaches in the molecular era. Nat Rev Clin Oncol 11:12-23,2014
3)Scott DW, Wright GW, Williams PM, et al:Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue. Blood 123:1214-1217,2014
4)Scott DW, Mottok A, Ennishi D, et al:Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies. J Clin Oncol 33:2848-2856,2015
5)Masqué-Soler N, Szczepanowski M, Kohler CW, et al:Molecular classification of mature aggressive B-cell lymphoma using digital multiplexed gene expression on formalin-fixed paraffin-embedded biopsy specimens. Blood 122:1985-1986
6)Mareschal S, Ruminy P, Bagacean C, et al:Accurate Classification of Germinal Center B-Cell-Like/Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Using a Simple and Rapid Reverse Transcriptase-Multiplex Ligation-Dependent Probe Amplification Assay: A CALYM Study. J Mol Diagn pii:S1525-S1578(15)00046-X,2015
7)Karube K, Campo E:MYC alterations in diffuse large B-cell lymphomas. Semin Hematol 52:97-106,2015
8)Swerdlow SH:Diagnosis of ‘double hit’ diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC. Hematology Am Soc Hematol Educ Program 2014:90-99,2014
9)Johnson NA, Slack GW, Savage KJ, et al:Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. J Clin Oncol 30:3452-3459,2012
10)Molina TJ, Canioni D, Copie-Bergman C, et al:Young patients with non-germinal center B-cell-like diffuse large B-cell lymphoma benefit from intensified chemotherapy with ACVBP plus rituximab compared with CHOP plus rituximab: analysis of data from the Groupe d'Etudes des Lymphomes de l'Adulte/lymphoma study association phase III trial LNH 03-2B. J Clin Oncol 32:3996-4003,2014
11)Pasqualucci L, Dalla-Favera R:The genetic landscape of diffuse large B-cell lymphoma. Semin Hematol 52:67-76,2015
12)Intlekofer AM, Younes A:Precision therapy for lymphoma--current state and future directions. Nat Rev Clin Oncol 11:585-596,2014
13)Dojcinov SD, Venkataraman G, Pittaluga S, et al:Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood 117:4726-4735,2011
14)Nicolae A, Pittaluga S, Abdullah S, et al:EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment. Blood 126:863-872,2015
15)Said J:The expanding spectrum of EBV+ lymphomas. Blood 126:827-828,2015
16)Dojcinov SD, Venkataraman G, Raffeld M, et al:EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol 34:405-417,2010
17)Hart M, Thakral B, Yohe S, et al:EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder. Am J Surg Pathol 38:1522-1529,2014
18)Love C, Sun Z, Jima D, et al:The genetic landscape of mutations in Burkitt lymphoma. Nat Genet 44:1321-1325,2012
19)Richter J, Schlesner M, Hoffmann S, et al:Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nat Genet 44:1316-1320,2012
20)Schmitz R, Young RM, Ceribelli M, et al:Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490:116-120,2012
21)Sander S, Calado DP, Srinivasan L, et al:Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis. Cancer Cell 22:167-179,2012
22)Salaverria I, Martin-Guerrero I, Wagener R, et al:A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma. Blood 123:1187-1198,2014
23)Ferreiro JF, Morscio J, Dierickx D, et al:Post-transplant molecularly defined Burkitt lymphomas are frequently MYC-negative and characterized by the 11q-gain/loss pattern. Haematologica 100:e275-e279,2015
24)Dave SS, Fu K, Wright GW, et al:Molecular diagnosis of Burkitt's lymphoma. N Engl J Med 354:2431-2442,2006
25)Hummel M, Bentink S, Berger H, et al:A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 354:2419-2430,2006
26)Campo E:MYC in DLBCL: partners matter. Blood 126:2439-2440,2015
27)Momose S, Weißbach S, Pischimarov J, et al:The diagnostic gray zone between Burkitt lymphoma and diffuse large B-cell lymphoma is also a gray zone of the mutational spectrum. Leukemia 29:1789-1791,2015
28)Gebauer N, Bernard V, Feller AC, et al:ID3 mutations are recurrent events in double-hit B-cell lymphomas. Anticancer Res 33:4771-4778,2013
29)Kluin P, et al:High grade B-cell lymphoma. In: WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues, 5th ed (Swerdlow SH, et al, eds). IARC Press, Lyon,in press
30)Swerdlow SH, Campo E, Pileri SA, et al:The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127:2375-2390,2016(http://www.bloodjournal.org/content/bloodjournal/127/20/2375.full.pdf)(2017年6月2日アクセス)

掲載誌情報

出版社:株式会社医学書院

電子版ISSN:1882-1367

印刷版ISSN:0485-1420

雑誌購入ページに移動
icon up
あなたは医療従事者ですか?